These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 6418263

  • 1. A phase II study of intravesical mitomycin C in the treatment of superficial bladder cancer.
    Harrison GS, Green DF, Newling DW, Richards B, Robinson MR, Smith PH.
    Br J Urol; 1983 Dec; 55(6):676-9. PubMed ID: 6418263
    [Abstract] [Full Text] [Related]

  • 2. Intravesical mitomycin C therapy for superficial bladder cancer. Report of a multicentre phase II study.
    MacFarlane JR, Tolley DA.
    Br J Urol; 1985 Feb; 57(1):37-9. PubMed ID: 3918605
    [Abstract] [Full Text] [Related]

  • 3. Allergy to mitomycin C complicating topical administration for urothelial cancer.
    Inglis JA, Tolley DA, Grigor KM.
    Br J Urol; 1987 Jun; 59(6):547-9. PubMed ID: 3120846
    [Abstract] [Full Text] [Related]

  • 4. Intravesical therapy of low stage bladder carcinoma with mitomycin C: comparison of results in untreated and previously treated patients.
    Prout GR, Griffin PP, Nocks BN, DeFuria MD, Daly JJ.
    J Urol; 1982 Jun; 127(6):1096-8. PubMed ID: 6806488
    [Abstract] [Full Text] [Related]

  • 5. Use of intravesical cisplatin and mitomycin-C for recurrent transitional cell carcinoma of bladder refractory to thiotepa.
    Mobley WC, Loening SA, Narayana AS, Culp DA.
    Urology; 1986 Apr; 27(4):335-9. PubMed ID: 3083555
    [Abstract] [Full Text] [Related]

  • 6. Mitomycin C resorption following repeated intravesical instillations using different instillation times.
    van Helsdingen PJ, Rikken CH, Sleeboom HP, de Bruyn EA, Tjaden UR.
    Urol Int; 1988 Apr; 43(1):42-6. PubMed ID: 3131943
    [Abstract] [Full Text] [Related]

  • 7. Renal failure after intravesical mitomycin C.
    Farha AJ, Krauss DJ.
    Urology; 1989 Oct; 34(4):216-7. PubMed ID: 2508290
    [Abstract] [Full Text] [Related]

  • 8. Treatment of superficial bladder cancer with intravesical mitomycin C: analysis of immediate and long-term response in 70 patients.
    Soloway MS.
    J Urol; 1985 Dec; 134(6):1107-9. PubMed ID: 3932684
    [Abstract] [Full Text] [Related]

  • 9. Recurrence of superficial bladder carcinoma after intravesical instillation of mitomycin-C. Comparison of exposure times.
    Giesbers AA, Van Helsdingen PJ, Kramer AE.
    Br J Urol; 1989 Feb; 63(2):176-9. PubMed ID: 2495144
    [Abstract] [Full Text] [Related]

  • 10. Role of intravesical mitomycin C in management of superficial bladder tumors.
    Bracken RB, Swanson DA, Johnson DE, De Furia D, von Eschenbach AC, Crooke S.
    Urology; 1980 Jul; 16(1):11-5. PubMed ID: 7395004
    [Abstract] [Full Text] [Related]

  • 11. Intravesical mitomycin C for the treatment of recurrent superficial bladder tumours.
    Hetherington JW, Newling DW, Robinson MR, Smith PH, Adib RS, Whelan P.
    Br J Urol; 1987 Mar; 59(3):239-41. PubMed ID: 3105631
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. First-line chemotherapy of superficial bladder cancer: mitomycin vs thiotepa.
    Heney NM.
    Urology; 1985 Oct; 26(4 Suppl):27-9. PubMed ID: 3931325
    [Abstract] [Full Text] [Related]

  • 14. Severe bladder contracture in patient receiving intravesical mitomycin C for superficial bladder cancer.
    Baker WC, Russo MA, deVere White RW.
    Urology; 1987 Oct; 30(4):357-8. PubMed ID: 3116739
    [Abstract] [Full Text] [Related]

  • 15. The effect of mitomycin C on superficial bladder cancer.
    Soloway MS, Murphy WM, DeFuria MD, Crooke S, Finebaum P.
    J Urol; 1981 May; 125(5):646-8. PubMed ID: 6785454
    [Abstract] [Full Text] [Related]

  • 16. Intravesical thiotepa and mitomycin C treatment immediately after transurethral resection and later for superficial (stages Ta and Tis) bladder cancer: a prospective, randomized, stratified study with crossover design.
    Zincke H, Benson RC, Hilton JF, Taylor WF.
    J Urol; 1985 Dec; 134(6):1110-4. PubMed ID: 3932685
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Side effects associated with intravesical mitomycin.
    Nissenkorn I, Herrod H, Soloway MS.
    J Urol; 1981 Nov; 126(5):596-7. PubMed ID: 6457917
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.